Practice Survey on Femoral Neck Fractures and the Incidence of Type of Anesthesia on Patient Outcome
Launched by ASTES · Jul 23, 2014
Trial Information
Current as of May 25, 2025
Withdrawn
Keywords
ClinConnect Summary
Inclusion of all patients with femoral neck fracture presenting in Saint-Luc Bouge Hospital between October 1th 2014 and September 30th 2015.
Comparison of severity scores of these patients and the scale of Nottingham on immediate (day 1 and day 2) and late (1 month) outcome.
This comparison includes preoperative parameters (hemoglobin, creatinine, mini-mental test) and intraoperative parameters (such as type of anesthesia).
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients admitted at the Saint-Luc Bouge Hospital for a femoral neck fractures between 10/01/2014 and 30/09/2014
- Exclusion Criteria:
- • None
About Astes
Astes is a leading clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing cutting-edge therapies and treatments, Astes collaborates with healthcare professionals and institutions to design and implement rigorous clinical studies. Their commitment to scientific excellence and patient safety drives their efforts in various therapeutic areas, ensuring that each trial adheres to the highest ethical and regulatory standards. By leveraging state-of-the-art technology and a robust network of clinical sites, Astes aims to accelerate the delivery of groundbreaking healthcare solutions to improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Namur, , Belgium
Patients applied
Trial Officials
Eric P DEFLANDRE, MD, FCCP
Principal Investigator
Astes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials